Helicobacter Pylori-induced Inflammation and Immune Responses Promote the Development of Atherosclerosis

Abstract

Abstract:

Helicobacter pylori infection is widely spread in the population. In recent years, the correlation between Helicobacter pylori infection and atherosclerotic disease has received increasing attention. The inflammatory response is the basis of atherosclerosis. The inflammation and immune responses caused by Helicobacter pylori infection can affect some cytokines, which may contribute to the occurrence and development of atherosclerosis. This paper reviews inflammatory factors associated with Helicobacter pylori infection and atherosclerosis to provide a reference for prevention and treatment of atherosclerotic artery diseases.

Key words: Atherosclerosis; Helicobacter pylori; Inflammation; Stroke; C-reactive protein

摘要：

幽门螺杆菌感染在人群中广泛存在，近年来幽门螺杆菌感染与动脉粥样硬化性疾病的相关性研究受到了越来越多的关注。炎症反应是动脉粥样硬化的基础，幽门螺杆菌感染引起的炎症和免疫反应可使体内多种与动脉粥样硬化相关的因子产生变化，从而可能促进动脉粥样硬化的发生和进展。本文就幽门螺杆菌感染与动脉粥样硬化相关的因子做一综述，为动脉粥样硬化性疾病的防治提供参考。

关键词: 动脉粥样硬化; 螺杆菌; 幽门; 炎症; 卒中; C反应蛋白

HU Zhen*, DING Su-Ju, QU Le-Feng.. Helicobacter Pylori-induced Inflammation and Immune Responses Promote the Development of Atherosclerosis [J]. Chinese Journal of Stroke, 2013, 8(01): 40-44.

胡震1，丁素菊1，曲乐丰2. 幽门螺杆菌感染与动脉粥样硬化相关炎症及免疫反应[J]. 中国卒中杂志, 2013, 8(01): 40-44.

References

中华人民共和国卫生部. 2010中国卫生统计年鉴[M/OL]. 北京:中国协和医科大学出版社, 2010[2012-10-25]. http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/index.htm.

Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352:1685-1695.

Gasbarrini G, Racco S, Franceschi F, et al. Helicobacter pylori infection:from gastric to systemic disease[J]. Recenti Prog Med, 2010, 101:27-33.

Farsak B, Yildirir A, Akyön Y, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR[J]. J Clin Microbiol, 2000, 38:4408-4411.

Kowalski M. Helicobacter pylori(H. pylori) infection in coronary artery disease:influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary ngioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque[J]. J Physiol Pharmacol, 2001, 52:3-31.

Elkind MS, Luna JM, Moon YP, et al. Infectious burden and carotid plaque thickness:the Northern Manhattan study[J]. Stroke, 2010, 41:e117-e122.

Sawayama Y, Ariyama I, Hamada M, et al. Association between chronic Helicobacter pylori infection and acute ischemic stroke:Fukuoka Harasanshin Atherosclerosis Trial(FHAT)[J]. Atherosclerosis, 2005, 178:303-309.

Ro?ankovi PB, Huzjan AL, Cupi H, et al. Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease[J]. J Neurol, 2011, 258:753-761.

陶珍, 曲乐丰, 丁素菊, 等. 颈动脉粥样硬化斑块内幽门螺杆菌-细胞毒素相关蛋白A-IgG抗体的表达与颈动脉粥样硬化性脑梗死的关系[J]. 上海医学, 2009, 4:296-298.

陶珍, 曲乐丰, 丁素菊, 等. 幽门螺杆菌感染致兔颈动脉粥样硬化模型的建立[J]. 第二军医大学学报, 2010, 31:37-41.

El-Mashad N, El-Emshaty WM, Arfat MS, et al. Relation of Cag-A-positive Helicobacter pylori strain and some inflammatory markers in patients with ischemic heart diseases[J]. Egypt J Immunol, 2009, 16:39-47.

Kebapcilar L, Bilgir O, Cetinkaya E, et al. The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels[J]. Clinics(Sao Paulo), 2010, 65:799-802.

Laurila A, Bloigu A, Näyhä S, et al. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 1997, 17:2910-2913.

Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease[J]. Heart, 1997, 78:273-277.

Adiloglu AK, Can R, Nazli C, et al. Ectasia and severe atherosclerosis:relationships with Chlamydia pneumoniae, Helicobacter pylori, and inflammatory markers[J]. Tex Heart Inst J, 2005, 32:21-27.

Hamed SA, Amine NF, Galal GM, et al. Vascular risks and complications in diabetes mellitus:the role of Helicobacter pylori infection[J]. J Stroke Cerebrovasc Dis, 2008, 17:86-94.

Wang CA, Liu YC, Du SY, et al. Helicobacter pylori neutrophil-activating protein promotes myeloperoxidase release from human neutrophils[J]. Biochem Biophys Res Commun, 2008, 377:52-56.

Nazligul Y, Aslan M, Horoz M, et al. The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected[J]. Clin Biochem, 2011, 44:647-649.

Ayub A, Mackness MI, Arrol S, et al. Serum paraoxonase after myocardial infarction[J]. Arterioscler Thromb Vasc Biol, 1999, 19:330-335.

Aslan M, Nazligul Y, Horoz M, et al. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects[J]. Atherosclerosis, 2008, 196:270-274.

Akbas HS, Basyigit S, Suleymanlar I, et al. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects[J]. Lipids Health Dis, 2010, 9:92.

Sabine IW, Charlotte L. ICAM-1:Contribution to Vascular Inflammation and Early Atherosclerosis[M]//Angelo S. Coronary Artery Disease-New Insights and Novel Approaches. Croatia:InTech, 2012:65-90.

Oshima T, Ozono R, Yano Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects[J]. J Am Coll Cardiol, 2005, 45:1219-1222.

Ameriso SF, Fridman EA, Leiguarda RC, et al. Detection of Helicobacter pylori in human carotid atherosclerotic plaques[J]. Stroke, 2001, 3:385-391.

Nicholls SJ, Wang Z, Koeth R, et al. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction[J]. Circulation, 2007, 116:2315-2324.

Marra M, Bonfigli AR, Bonazzi P, et al. Asymptomatic Helicobacter pylori infection increases asymmetric dimethylarginine levels in healthy subjects[J]. Helicobacter, 2005, 10:609-614.

Aydemir S, Eren H, Tekin IO, et al. Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels[J]. Mediators Inflamm, 2010, 2010:685903.

Ayada K, Yokota K, Hirai K, et al. Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis[J]. Lupus, 2009, 18:1154-1168.

Lenzi C, Palazzuoli A, Giordano N, et al. H. pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease[J]. World J Gastroenterol, 2006, 12:7815-7820.

Zhu J, Quyyumi AA, Rott D, et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease:evidence for an autoimmue component of atherogensis[J]. Circulation, 2001, 103:1071-1075

[1]	CAO Liming, REN Lijie. Progress and Prospects of Diagnosis and Treatment Techniques for Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 983-989.
[2]	FU Pengcheng, CAO Liming, ZHU Jiaqian, ZHAO Guiyu, XU Gelin. Research Progress of Reperfusion Therapy for Large Artery Atherosclerotic Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1004-1011.
[3]	ZHANG Liping, CAO Liming, XIAO Nan, LIAO Yuqi, CHI Feng, YU Yanni, REN Lijie. Research Progress and Challenges of Nanomaterials in the Diagnosis and Treatment of Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1012-1017.
[4]	JIANG He, WANG Cheng, CHEN Xianghua, XU Chunxiang. Predictive Value of Five Prehospital Stroke Screening Scales for In-Hospital Acute Large Vessel Occlusive Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1018-1024.
[5]	WANG Xiaorui, LUO Song, ZOU Liangyu, QU Hongdang, CUI Xue, ZHAO Yujie. Value of Eosinophil-to-Monocyte Ratio in Predicting the Prognosis of Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(9): 1025-1033.
[6]	WANG Shuo, YU Ping, ZHANG Ning, WANG Chunxue. Bibliometric Analysis of References on the Correlation between Ischemic Stroke and Sleep from 2013 to 2023 [J]. Chinese Journal of Stroke, 2024, 19(9): 1040-1047.
[7]	ZHOU Hongyu, LI Zixiao, WANG Yongjun. Research Progress on Radiomics-Based Brain Age Prediction and Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1066-1076.
[8]	ABULANIYAZI Anaguli, WU Xiaoxin, LI Jiaoxing, LI Zhuhao, SHENG Wenli. Research Progress on Factors Related to the Susceptibility Vessel Sign and its Clinical Application in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1077-1085.
[9]	YANG Jinbo, ZHANG Cong. Progress on the Application of High-Resolution Vessel Wall Imaging in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1086-1093.
[10]	WU Chunyan, YIN Yashi, WANG Guangzhi, YUE Kuitao. Evaluation and Application of Medical Imaging for Acute Ischemic Stroke at Different Time Windows: A Review [J]. Chinese Journal of Stroke, 2024, 19(9): 1094-1101.
[11]	WANG Ye, WEI Chenming, LI Xiuli, WU Jian. Application of Diversified Teaching Model in Stroke Green Channel Training at a Medical University-Affiliated Teaching Hospital [J]. Chinese Journal of Stroke, 2024, 19(9): 1102-1109.
[12]	SHAN Kai, ZHAO Meng, WANG Chunjuan, LI Zixiao, WANG Xiaoyan. Exploration and Practice of Diagnosis and Treatment Models for Stroke and Comorbid Conditions [J]. Chinese Journal of Stroke, 2024, 19(8): 863-865.
[13]	ZHANG Mengruo, XU Shouchen, SUI Cuicui, LI Yukui, WANG Xueli. The Effects of Lower Limb Rehabilitation Robot Combined with Scalp Acupuncture on the Walking Efficiency and Coordination Function in Elderly Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(8): 902-908.
[14]	XUE Mingyue, ZHANG Huixin, SU Dan, LI Lixia, LI Jingwei, LI Hong. Analysis of the Influencing Factors of Medication Adherence in Ischemic Stroke Patients [J]. Chinese Journal of Stroke, 2024, 19(8): 909-914.
[15]	WU Yuqian, ZHANG Yumei, ZANG Dawei, FAN Xiaowei, WANG Anxin, ZHANG Xiaoli, MENG Xia. Study on the Reliability, Validity, and Sensitivity of Action Research Arm Test Scale in Evaluating the Function of Hemiplegic Upper Limb and Hand in Subacute Stage Ischemic Stroke Patients [J]. Chinese Journal of Stroke, 2024, 19(8): 915-923.